- Live Meeting -

Cutting Edge 2009: Research Updates in Neurology
What's New and Relevant in Multiple Sclerosis and Parkinson's Disease 

Program Description

Multiple sclerosis (MS) and Parkinson's disease (PD) are progressive disorders of the central nervous system for which there is no cure. Early and aggressive management is important in optimizing the quality of life of patients with either of these diseases. This educational program is intended to bring cutting-edge research presented nationally in 2009 to the local level, and to define the implications of this research in the management of MS and PD. Healthcare providers specializing in neurology will be able to incorporate the latest research findings into their local practice, supporting the highest level of evidence-based patient care.

Learning Objectives

Upon completion of this CME activity, neurologists and neurology nurses will be able to:

• Describe recent research findings in PD management, including those that demonstrate the potential for therapies to modify the disease course, reduce progression of nonmotor symptoms, and avoid adverse food and drug reactions

• Explain the implications of the latest research findings in MS regarding autoimmune disease processes, newer imaging techniques, and potentially disease-modifying oral therapies

Program Chairmen

Adil Javed, MD, PhD
Assistant Professor
Department of Neurology
University of Chicago
Chicago, Illinois

Rajesh Pahwa, MD
Laverne and Joyce Rider Professor of Neurology
Director, Parkinson Disease and Movement Disorder Center
University of Kansas Medical Center
Kansas City, Kansas

CE Accreditation:

Physicians:
This activity has been planned and implemented in accordance with the essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of ProCE, Inc. and the National Association of Managed Care Physicians (NAMCP).

The NAMCP is accredited by the ACCME to provide continuing medical education (CME) to physicians. The NAMCP designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits^TM Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses:
Nursing credit is provided through collaboration between ProCE, Inc. and Wild Iris Medical Education, Inc. Wild Iris Medical Education, WSNA CEARP Provider number PA-5/Feb/11, is an approved provider of continuing education by the Washington State Nurses Association, an accredited approver by the American Nurses' Credentialing Center's Commission on Accreditation. California Board of Registered Nursing Provider #12300. This activity provides 1.5 contact hours of nurse CE credit.

Funding

This program has been made possible through an educational grant from TEVA Neuroscience.

Disclosure
It is the policy of ProCE to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) discussed in an educational presentation. Faculty conflict of interest disclosure will be announced at the beginning of the CME activity. The planners of this activity have no real or perceived financial relationships to disclose.

Please note: The opinions expressed in this program should not be construed as those of the CME / CE provider. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this program may include the use of drugs for unlabeled indications. Use of drugs outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.